CG Oncology, Inc. (CGON)
CG Oncology Market Cap : 5.471B for May 1, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.509B |
| Puma Biotechnology, Inc. | 380.81M |
| Syndax Pharmaceuticals, Inc. | 1.692B |
| UroGen Pharma Ltd. | 1.119B |
| Cogent Biosciences, Inc. | 6.261B |
Market Cap Related Metrics
| PS Ratio | 1267.02 |
| PEG Ratio | -0.6025 |
| Price to Book Value | 7.269 |
| Price | 66.21 |
| Earnings Yield | -3.14% |
| PEGY Ratio | -0.6025 |